Literature DB >> 10671652

Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes.

M N Barnes1, L C Kilgore.   

Abstract

Endometrial adenocarcinoma is the most common gynecologic malignancy. Strategies for treatment of this disease should not only emphasize quality of care resulting in cure of disease, but also use health care resources in the most efficient manner possible. Based on available data, we recommend that all patients with the diagnosis of endometrial carcinoma undergo complete surgical staging with lymph node dissection. Radiation therapy is reserved only for patients with evidence of extrauterine disease. This approach maximizes the amount of information available for treatment planning and offers the potential therapeutic advantage of lymph node dissection. Additionally, in a cost analysis, this approach appears to be the most cost-effective.

Entities:  

Mesh:

Year:  2000        PMID: 10671652     DOI: 10.1016/s1053-4296(00)80014-4

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  8 in total

1.  Comparison of preoperative endometrial biopsy grade and final pathologic diagnosis in patients with endometrioid endometrial cancer.

Authors:  Behiye Pınar Çilesiz Göksedef; Ozgür Akbayır; Aytül Corbacıoğlu; Hakan Güraslan; Fatmagül Sencan; Onur Erol; Ahmet Cetin
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-06-01

2.  Changing Practice of Gynecologic Oncology based on Current Evidence.

Authors:  Hemant B Tongaonkar
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Risk factors for paraaortic lymph node metastasis in endometrial cancer.

Authors:  Mustafa Erkan Sari; İbrahim Yalcin; Hanifi Sahin; Mehmet Mutlu Meydanli; Tayfun Gungor
Journal:  Int J Clin Oncol       Date:  2017-05-18       Impact factor: 3.402

4.  Association of Tumor Size With Myometrial Invasion, Lymphovascular Space Invasion, Lymph Node Metastasis, and Recurrence in Endometrial Cancer: A Meta-Analysis of 40 Studies With 53,276 Patients.

Authors:  Xiaoying Jin; Chunjuan Shen; Xiaodi Yang; Yayuan Yu; Jianzhang Wang; Xuan Che
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

5.  Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the Women's Health Initiative.

Authors:  Hannah Arem; Rowan Chlebowski; Marcia L Stefanick; Garnet Anderson; Jean Wactawski-Wende; Stacy Sims; Marc J Gunter; Melinda L Irwin
Journal:  Gynecol Oncol       Date:  2012-11-02       Impact factor: 5.482

6.  Selective lymphadenectomy in endometrial cancer: Retrospective analysis of morbidity and survival data at a tertiary care centre.

Authors:  Uzma Chishti; Aliya B Aziz; Munazza Akhtar; Sana Sheikh
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

7.  Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer.

Authors:  N Povolotskaya; N Das; K Dhar; D Brinkmann; F Gardner; R Woolas
Journal:  Surg Res Pract       Date:  2014-02-27

Review 8.  Endometrial carcinoma.

Authors:  W K Huh; J M Straughn; F J Kelly; L C Kilgore
Journal:  Curr Treat Options Oncol       Date:  2001-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.